Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

LifeStance Health Group, Inc. (LFST) Cash Flow Statement

LifeStance Health Group, Inc. (LFST) generated $217.9M of operating cash flow over the twelve months to 2026-06-30, spent $44.0M on capital expenditure and had free cash flow of $173.9M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LFSTLifeStance Health Group, Inc.Follow LFST — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
4.9B
P/E TTM
99.7
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow0.010.05-0.020.110.150.22
Capital expenditure0.090.080.040.020.04-0.04
Free cash flow-0.09-0.03-0.060.090.110.17
Stock-based compensation0.260.190.100.080.07—

USD billions · SEC XBRL

LifeStance Health Group, Inc. — questions

What is LifeStance Health Group, Inc.'s operating cash flow?
$217.9M over the twelve months to 2026-06-30.
How much does LifeStance Health Group, Inc. spend on capital expenditure?
$44.0M over the twelve months to 2026-06-30.
What is LifeStance Health Group, Inc.'s free cash flow?
$173.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from LifeStance Health Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.